Overview

A Randomized Phase II Study of SUBATM-itraconazole in Patients With Untreated Squamous NSCLC.

Status:
Terminated
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
Response rates. Changes in tumor blood flow.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Treatments:
Cisplatin
Gemcitabine
Hydroxyitraconazole
Itraconazole